Department of Pharmacology, V. P. Chest Institute, University of Delhi, Delhi, India.
Amity Institute of Public Health, Amity Institute, NOIDA, Uttar Pradesh, India; Center for Disease Dynamics & Economic Policy, New Delhi, India.
Indian J Med Microbiol. 2021 Apr;39(2):184-187. doi: 10.1016/j.ijmmb.2020.12.003. Epub 2020 Dec 16.
Antimicrobial resistance (AMR) is a complex public health problem requiring coordinated efforts by a multitude of public and private sector stakeholders. Over-the-counter (OTC) antibiotics sale is contributing to rising AMR. We applied NetMap, a research tool to identify, prioritize and assess relationships among stakeholders, also to identify the stakeholders that must be engaged for regulating antibiotic OTC sale for humans in India.
Through a one-day workshop, a team of expert facilitators engaged with a mixed group of stakeholders-regulators, drug manufacturers, retailers and consumers of antibiotics to identify and rank stakeholders based on their role, power/interest and influence. Stakeholders were listed and grouped as per the type of agency represented. Carrom discs were stacked against each stakeholder with the height of stack reflecting perceived power.
A total of 25 stakeholders were identified from government, non-government, private/corporate, academic and research agencies and the general public. Based on the stacking exercise, a power/interest matrix was developed with six stakeholders having high power and high interest, five having high power but low interest, six having low power but high interest and eight having low power. A visual NetMap was developed to position the stakeholders as proximal, middle and distal based on their perceived influence.
NetMap can be used with stakeholders with varying skill sets. It is a useful project initiation tool that was successfully used to prioritize stakeholders for reaching out, for targeted outreach and development of customized tools for developing innovative regulation for tackling OTC sale of antibiotics. It also pre-empted any conflict of interests.
抗菌药物耐药性(AMR)是一个复杂的公共卫生问题,需要众多公共和私营部门利益攸关方共同努力。非处方(OTC)抗生素的销售助长了 AMR 的上升。我们应用 NetMap,这一研究工具来识别、优先考虑和评估利益相关者之间的关系,也确定了在印度监管人类 OTC 抗生素销售的利益相关者。
通过为期一天的研讨会,一组专家主持人与混合的利益相关者——监管者、抗生素制造商、零售商和消费者——进行了接触,根据他们的角色、权力/利益和影响力对利益相关者进行了识别和排名。根据代表的机构类型对利益相关者进行了列名和分组。卡罗姆圆盘被堆放在每个利益相关者的旁边,圆盘的高度反映了感知到的权力。
共从政府、非政府、私营/企业、学术和研究机构以及公众中确定了 25 个利益相关者。基于堆叠练习,制定了一个权力/利益矩阵,其中 6 个利益相关者具有高权力和高利益,5 个利益相关者具有高权力但低利益,6 个利益相关者具有低权力但高利益,8 个利益相关者具有低权力。根据感知到的影响力,开发了一个 NetMap 来将利益相关者定位为近端、中端和远端。
NetMap 可以与具有不同技能的利益相关者一起使用。它是一个有用的项目启动工具,成功地用于为目标接触和发展定制工具来制定创新的监管规定,以解决 OTC 销售抗生素的问题,对优先级别的利益相关者进行了优先排序。它还预先避免了任何利益冲突。